Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2007
10/24/2007CN101057678A Composition containing natural plant extraction or monomer
10/24/2007CN101057674A Composition for preventing and curing diabetes
10/24/2007CN101057640A Fine dried noodles containing chromium, glossy ganoderma and carrot and its processing method
10/24/2007CN101057619A Help producing saliva and slaking thirst, softening blood vessel, promoting blood circulation health tea
10/24/2007CN101057614A Heat-clearing eyesight-improving bowels-relaxing health tea
10/24/2007CN101057613A Heat-clearing and antitoxic heart-soothing and sedative tea
10/24/2007CN100344957C Method for measuring total flavone content in compositions extracted from gingko biloba leaves
10/24/2007CN100344648C Cyclosporine analogue mixtures and their use as immunomodulating agents
10/24/2007CN100344646C Oligonucleotide-containing pharmacological compositions and their use
10/24/2007CN100344638C Aminophosphonic acid derivatives, addition salts thereof and S1P receptor modulators
10/24/2007CN100344632C 稠合的呋喃化合物 Fused furan compound
10/24/2007CN100344618C N-benzyl acryloyl substituted tyrosine derivatives as hPPAR alpha and hPPAR gamma agonist
10/24/2007CN100344616C Compounds for the treatment of metabolic disorders
10/24/2007CN100344322C Medicine for treating cardiopathy and its preparation method
10/24/2007CN100344303C Wet pad for treating piles
10/24/2007CN100344290C Breviscapine dispersing tablet and its prepn
10/24/2007CN100344279C Application of schisanhenol for preparing medicine for treating ischemic brain apoplexy
10/23/2007US7285683 Bicyclic and tricyclic cannabinoids
10/23/2007US7285680 β-alanine derivatives and the use thereof
10/23/2007US7285666 Pyrazolo[1,5-a] pyridines and medicines containing the same
10/23/2007US7285664 Heterocyclic or benzenic derivatives of lipoic acid, their preparation and their use as medicaments
10/23/2007US7285662 Therapeutic heterocyclic compounds
10/23/2007US7285635 Reducing the antigenicity of a proteinaceous compound while maintaining the compound's biological activity
10/23/2007US7285562 Derivatives of 2-mercaptobenzothiazole, 2-mercaptobenzoxazole, 2-mercaptothiazolo[5,4-b]pyridine, or 2-mercaptooxazolo[5,4-b]pyridine; cardiovascular disorders, diabetes, cancer and obesity
10/23/2007US7285560 E.g., N-[(S)-2-diphenylamino-1-(5-oxo-4,5-dihydro[1,3,4]oxadizol-2-yl)ethyl]-2-(2-methylaminopyrimidin-4-yl)-1H-indole-5-carboxamide; used for treating rheumatoid arthritis, osteoarthritis, asthma, cardiac infarction, Alzheimer's diseases, cancer diseases or atherosclerosis
10/23/2007US7285549 Sulfamides and their use as endothelin receptor antagonists
10/23/2007US7285543 Purine inhibitors of fructose-1,6-bisphosphatase
10/23/2007CA2334910C New use of a pyridazinone derivative
10/18/2007WO2007118136A2 Method for creating a stratigraphic model using pseudocores created from borehole images
10/18/2007WO2007118051A2 Lipid therapy
10/18/2007WO2007118023A1 Renin inhibitors for the treatment of hypertension
10/18/2007WO2007117982A2 Organic compounds
10/18/2007WO2007117577A2 High affinity human antibodies to human il-18 receptor
10/18/2007WO2007117560A2 Piperidine and morpholine renin inhibitors
10/18/2007WO2007117482A2 Renin inhibitors
10/18/2007WO2007116916A1 Liquid drug preparation for oral administration
10/18/2007WO2007116901A1 Novel arylamide derivative
10/18/2007WO2007116297A2 Use of aminapthone for the preparation of a medicament for treating arteriophaties
10/18/2007WO2007116138A1 Use of an anti-atherothrombotic compound for the production of medicaments for use in the treatment of vascular disorders
10/18/2007WO2007116106A1 Novel compounds as antagonists of adenosine a1 receptors
10/18/2007WO2007116100A1 Condensed imidazole derivatives as aromatase inhibitors
10/18/2007WO2007116097A1 Condensed imidazole derivatives as aldosterone synthase inhibitors
10/18/2007WO2007115822A1 Thienopyrimidines having mnkl /mnk2 inhibiting activity for pharmaceutical compositions
10/18/2007WO2007115808A1 Arginine prodrugs with high therapeutic activity
10/18/2007WO2007115473A1 Pyrrole derivatives inhibitors, their curative uses
10/18/2007WO2007115398A1 Treatment of elevated c-reactive protein levels
10/18/2007WO2007115376A1 Anti-angiogenic agents and methods of their use
10/18/2007WO2007077457A9 Treatment of equine laminitis with 5-ht1b/ 1d antagonists
10/18/2007WO2007071038A3 Compositions comprising one or more phytosterols and/or phytostanols, or derivatives thereof, and high hlb emulsifiers
10/18/2007WO2005037780A3 Amidomethyl-substituted 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2h-chromium-6-yl-derivatives and drugs containing said compounds
10/18/2007WO2003061560A3 Replication competent dual-ad vectors for vaccine and immunotherapy applications
10/18/2007US20070244182 Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment
10/18/2007US20070244181 Carvedilol dihydrogen phosphate dihydrate; crystal structure; x-ray patterns; mixed venous/arterial vasodilation; non-cardioselective, beta-adrenergic blocking agents; hypotensive agents, congestive heart failure; angina;water solubility; stability; prolonged G.I. bioavailabilty in pH regions
10/18/2007US20070244172 Compounds for the treatment of metabolic disorders
10/18/2007US20070244171 Compounds for the treatment of metabolic disorders
10/18/2007US20070244170 Novel Pyrrole Derivatives with Angiotensin II Antagonist Activity
10/18/2007US20070244141 Compounds for the treatment of metabolic disorders
10/18/2007US20070244139 Indole Derivatives or Benzimidazole Derivatives for Modulating IkB Kinase
10/18/2007US20070244127 Stable Dosage Form of Phenylalanine Derivatives
10/18/2007US20070244123 Heterocycle-carboxamide derivatives as raf kinase inhibitors
10/18/2007US20070244108 Phenylsulfonamide Derivatives for Use as 11-Beta-Hydroxysteroid Dehydrogenase Inhibitors
10/18/2007US20070244107 Method of Treating Atherosclerosis, Dyslipidemias and Related Conditions
10/18/2007US20070244099 Such as 4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidine-1-carboxylic acid-{(R)-1-(3,4-diethyl-benzyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amide; calcitonin gene related peptide (CGRP); for treatment of migraines; radioimmunoassay
10/18/2007US20070243609 Cell populations which co-express CD49c and CD90
10/18/2007US20070243588 Blood coagulation factor; nucleotide sequence encodes polypeptide; amino acid sequence differs in 1-15 amino acid residues and comprises an introduced in vivo N-glycosylation site; substitution V253N; coagulation related disorders
10/18/2007US20070243268 Compositions for regulating intestinal disorders and methods of use thereof
10/18/2007US20070243231 Use of Whey Permeate for the Treatment of Metabolic Syndrome
10/18/2007US20070243226 Growth factor complex
10/18/2007US20070243189 Blood VEGF level-lowering agent containing IL-6 antagonist as the active ingredient
10/18/2007US20070243175 Methods and compositions for regenerating tissue
10/18/2007US20070243174 Methods and compositions for directing stem cells to the liver
10/18/2007US20070243173 Methods and compositions for directing stem cells to the heart
10/18/2007CA2651898A1 Thienopyrimidines having mnk1/mnk2 inhibiting activity for pharmaceutical compositions
10/18/2007CA2649214A1 Condensed imidazole derivatives as aromatase inhibitors
10/18/2007CA2645260A1 Renin inhibitors for the treatment of hypertension
10/18/2007CA2644783A1 Selective hydroxamate based mmp inhibitors
10/18/2007CA2644391A1 Organic compounds
10/17/2007EP1845106A1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction
10/17/2007EP1845104A1 Par-2 agonist
10/17/2007EP1845081A1 Amide compound
10/17/2007EP1844774A2 A pharmaceutical composition for angiotensin II-mediated diseases
10/17/2007EP1844768A1 Aromatic sulfone compound as aldosterone receptor modulator
10/17/2007EP1844018A2 Crystalline forms fenoldopam mesylate
10/17/2007EP1844009A1 Compositions and methods for treating cardiovascular disorders
10/17/2007EP1844006A2 Taurine synthesis, production and utility as a medicine
10/17/2007EP1844003A1 Novel biaromatic compounds, inhibitors of the p2x7-receptor
10/17/2007EP1844002A1 1-acylamino-2-hydroxy-3-amino-w-arylalkanes as renin inhibitors
10/17/2007EP1843791A1 Treatment of degenerative diseases with the x-linked inhibitor of apoptosis
10/17/2007EP1843772A1 Intravenous formulations of pde-5 inhibitors
10/17/2007EP1843771A2 Use of pyrimidylaminobenzamides for the treatment of diseases that respond to modulation of tie-2 kinase activity
10/17/2007EP1843769A1 Fast-disintegrating dosage forms of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene
10/17/2007EP1843764A2 Medicaments for the prevention or treatment of heart failure comprising administration of an anticholinergic
10/17/2007EP1843760A1 Classes of compounds that interact with integrins
10/17/2007EP1843754A1 New pharmaceutical composition containing candesartan cilexetil as lipophilic crystalline substance
10/17/2007EP1648564B1 Cyanoamide compounds useful as malonyl-coa decarboxylase inhibitors
10/17/2007EP1592669B1 Substituted 2-aminoimidazoles, method for the production thereof, their use as a medicament or as a diagnostic reagent, and medicament containing these compounds
10/17/2007EP1474395B1 Nicotinamide derivates useful as p38 inhibitors
10/17/2007EP1420771B9 Use of trifluoroacetyl alkyl-substituted phenyl derivatives, phenol derivatives, and benzoyl derivatives in the treatment and/or prophylaxis of obesity and accompanying diseases and/or secondary diseases
10/17/2007EP1392713B1 Liver x receptor agonists
10/17/2007EP1347745A4 Dietary composition containing conjugated linoleic acid and calcium for improved health
1 ... 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 ... 1595